Home/Filings/4/0001562180-20-001613
4//SEC Filing

Pena Luis C. 4

Accession 0001562180-20-001613

CIK 0001557883other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 7:31 PM ET

Size

37.2 KB

Accession

0001562180-20-001613

Insider Transaction Report

Form 4
Period: 2020-02-20
Pena Luis C.
EVP Product Development
Transactions
  • Disposition to Issuer

    Employee Stock Options (Right to buy)

    2020-02-2071,3970 total
    Exercise: $1.74Exp: 2023-07-10Common Stock (71,397 underlying)
  • Disposition to Issuer

    Stock Options (Right to buy)

    2020-02-2032,5060 total
    Exercise: $1.22Exp: 2023-01-03Common Stock (32,506 underlying)
  • Disposition to Issuer

    Stock Options (Right to buy)

    2020-02-2050,1780 total
    Exercise: $16.00Exp: 2024-10-01Common Stock (50,178 underlying)
  • Disposition to Issuer

    Employee Stock Options (Right to buy)

    2020-02-2048,7500 total
    Exercise: $33.84Exp: 2027-02-16Common Stock (48,750 underlying)
  • Disposition to Issuer

    Employee Stock Options (Right to buy)

    2020-02-2065,0000 total
    Exercise: $7.42Exp: 2029-02-11Common Stock (65,000 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2020-02-206,3780 total
    Common Stock (6,378 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2020-02-2025,0000 total
    Common Stock (25,000 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2020-02-2015,0000 total
    Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Options (Right to buy)

    2020-02-2088,2510 total
    Exercise: $0.99Exp: 2021-10-03Common Stock (88,251 underlying)
  • Disposition to Issuer

    Stock Options (Right to buy)

    2020-02-2060,0000 total
    Exercise: $26.37Exp: 2026-02-04Common Stock (60,000 underlying)
  • Disposition to Issuer

    Stock Options (Right to buy)

    2020-02-2017,0620 total
    Exercise: $16.00Exp: 2024-10-01Common Stock (17,062 underlying)
  • Disposition to Issuer

    Employee Stock Options (Right to buy)

    2020-02-2010,0000 total
    Exercise: $26.37Exp: 2026-02-04Common Stock (10,000 underlying)
  • Disposition to Issuer

    Employee Stock Options (Right to buy)

    2020-02-2063,7500 total
    Exercise: $28.25Exp: 2028-02-14Common Stock (63,750 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2020-02-202,4370 total
    Common Stock (2,437 underlying)
  • Disposition to Issuer

    Common Stock

    2020-02-20$18.75/sh18,233$341,8690 total
Footnotes (4)
  • [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated January 10, 2020, by and among Dermira, Inc. ("Dermira"), Eli Lilly and Company, an Indiana corporation ("Lilly"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly ("Merger Sub"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the "Merger"), effective as of February 20, 2020. Pursuant to the Merger Agreement, each issued and outstanding share (the "Shares") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the "Offer Price"), net to the seller in cash, without interest, and subject to withholding taxes.
  • [F2]Includes 1,024 shares of Dermira Common Stock acquired by the Reporting Person pursuant to Dermira's Employee Stock Purchase Plan.
  • [F3]Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time.
  • [F4]Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit ("RSU"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price.

Issuer

Dermira, Inc.

CIK 0001557883

Entity typeother

Related Parties

1
  • filerCIK 0001620548

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 7:31 PM ET
Size
37.2 KB